OPRA FLOW is an integrated, process-first compliance and quality management platform for the safe and efficient development, manufacture and post-market operation of medical devices. The modular OPRA FLOW platform is implemented across every stage of the device lifecycle – research, startup product development and full-scale enterprise manufacturing , in the highly regulated, safety-critical medical device sector, for operational excellence, audit readiness and accelerated time to market.
The key feature of the OPRA FLOW approach is the rigorous integration of a single traceability spine, linking user needs, requirements, risk, design history, documents and quality events in one connected data model so every module reads and writes the same real-world state of the device programme, rather than reconstructing it from disconnected spreadsheets and shared drives. This process-first architecture, augmented with AI-assisted authoring under full customer control of data and models, turns audit-ready documentation into a live by-product of correct engineering practice, not a retrospective compliance exercise.
OPRA FLOW is on a mission to make operational excellence achievable for every medical device organisation, in a sector where more than 1,500 new MedTech startups are founded in the UK alone each year against a global eQMS and regulatory affairs software market estimated at $12B, yet most teams still run on legacy, pharma-built platforms, generic project tools and manual paperwork never designed for how regulated products are actually built. OPRA FLOW is revolutionising this fragmented, document-first status quo with a connected, modular platform and letting research groups, startups and established manufacturers each adopt only what they need, when they need it, and scale one compliant system as their product and organisation grow.